Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Celebrex, Celecoxib

Celebrex, Celecoxib News Editors

News Widget

Display the Celebrex, Celecoxib news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Celebrex, Celecoxib News

News on Celebrex, Celecoxib (generic) continually updated from thousands of sources around the net.

Friday May 3 | Seeking Alpha

Ampio Pharma Initiates Phase III, Investors Extend Momentum

Shares of Ampio Pharmaceuticals are on a roll after the company reported on April 24th that it completed enrollment for its Phase III run-in trial with Ampion, a naturally occurring anti-inflammatory compound that is under development for the treatment of osteoarthritis of the knee.

Comment?

Related Topix: Medicine, Arthritis, Health, Food and Drug Administration, Advil, Motrin, Nuprin, Ibuprofen (generic), Pain, Mobic, Meloxicam (generic)

Tue Apr 30, 2013

NewsTarget.com

Top three most dangerous pain medications

Pain medications and the adverse drug reactions to them are the fourth leading cause of death in the US.

Comment?

Related Topix: Drugs, Medicine, Advil, Motrin, Nuprin, Ibuprofen (generic), Naproxen (generic), Aleve, Naprosyn

Fri Apr 26, 2013

Health News Digest

Some Pain Drugs Increase the Risk of Heart Attack

ROCHESTER, Minn. - Some of the most common pain drugs used by older adults who experience discomfort in muscles and joints can increase the risk of heart attack and stroke.

Comment?

Related Topix: Heart Attack, Health, Medicine, Pain, Rochester, MN, Stroke

Thu Apr 25, 2013

BioSpace

Pfizer Inc.'s Celebrex Meets Goals in Juvenile Rheumatoid Arthritis Study

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! NEW YORK-- -- Pfizer Inc.

Comment?

Related Topix: Medicine, Arthritis, Health, Rheumatoid Arthritis, Pfizer, Biotech, Healthcare Industry, Excaliard Pharmaceuticals

Wed Apr 10, 2013

AmericanBankingNews.com

Inflavestin, a new weapon in the battle against osteoarthritis pain.

In a recent clinical trial, 60 subjects aged between 40 and 75 with moderate to severe osteoarthritis of the hip and knee were administered Inflavestin, a proprietary blend of Scutellaria biacalensis and Acacia catechu.

Comment?

Related Topix: Medicine, Osteoarthritis, Health, Arthritis, Pain